These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11908641)

  • 1. Studies of the ceruloplasmin-lactoferrin complex.
    Pulina MO; Zakharova ET; Sokolov AV; Shavlovski MM; Bass MG; Solovyov KV; Kokryakov VN; Vasilyev VB
    Biochem Cell Biol; 2002; 80(1):35-9. PubMed ID: 11908641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and isolation from breast milk of ceruloplasmin-lactoferrin complex.
    Sokolov AV; Pulina MO; Zakharova ET; Susorova AS; Runova OL; Kolodkin NI; Vasilyev VB
    Biochemistry (Mosc); 2006 Feb; 71(2):160-6. PubMed ID: 16489920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of lactoferrin with ceruloplasmin.
    Zakharova ET; Shavlovski MM; Bass MG; Gridasova AA; Pulina MO; De Filippis V; Beltramini M; Di Muro P; Salvato B; Fontana A; Vasilyev VB; Gaitskhoki VS
    Arch Biochem Biophys; 2000 Feb; 374(2):222-8. PubMed ID: 10666301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of ceruloplasmin, lactoferrin, and myeloperoxidase.
    Sokolov AV; Pulina MO; Ageeva KV; Ayrapetov MI; Berlov MN; Volgin GN; Markov AG; Yablonsky PK; Kolodkin NI; Zakharova ET; Vasilyev VB
    Biochemistry (Mosc); 2007 Apr; 72(4):409-15. PubMed ID: 17511605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Interaction between Ceruloplasmin and Lactoferrin/Transferrin: to Bind or Not to Bind.
    Sokolov AV; Voynova IV; Kostevich VA; Vlasenko AY; Zakharova ET; Vasilyev VB
    Biochemistry (Mosc); 2017 Sep; 82(9):1073-1078. PubMed ID: 28988537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lactoferrin on the ferroxidase activity of ceruloplasmin.
    Sokolov AV; Pulina MO; Zakharova ET; Shavlovski MM; Vasilyev VB
    Biochemistry (Mosc); 2005 Sep; 70(9):1015-9. PubMed ID: 16266273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical characteristics and polymerization during iron saturation of lactoferrin, a myelopoietic regulatory molecule with suppressor activity.
    Mantel C; Miyazawa K; Broxmeyer HE
    Adv Exp Med Biol; 1994; 357():121-32. PubMed ID: 7762423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human milk lactoferrin binds ATP and dissociates into monomers.
    Semenov DV; Kanyshkova TG; Buneva VN; Nevinsky GA
    Biochem Mol Biol Int; 1999 Feb; 47(2):177-84. PubMed ID: 10205662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the ceruloplasmin: lactoferrin complex in solution.
    Sabatucci A; Vachette P; Vasilyev VB; Beltramini M; Sokolov A; Pulina M; Salvato B; Angelucci CB; Maccarrone M; Cozzani I; Dainese E
    J Mol Biol; 2007 Aug; 371(4):1038-46. PubMed ID: 17597152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lactoferrin on oxidative features of ceruloplasmin.
    Sokolov AV; Ageeva KV; Pulina MO; Zakharova ET; Vasilyev VB
    Biometals; 2009 Jun; 22(3):521-9. PubMed ID: 19189056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro effects of lactoferrin on Yersinia pseudotuberculosis.
    Salamah AA; al-Obaidi AS
    New Microbiol; 1995 Jul; 18(3):267-74. PubMed ID: 7553361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in serum concentrations of C-reactive protein, ceruloplasmin, lactoferrin and myeloperoxidase and their interactions during normal human pregnancy and postpartum period.
    Skarżyńska E; Zborowska H; Jakimiuk AJ; Karlińska M; Lisowska-Myjak B
    J Trace Elem Med Biol; 2018 Mar; 46():83-87. PubMed ID: 29413114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro interaction between ceruloplasmin and human serum transferrin.
    Ha-Duong NT; Eid C; Hémadi M; El Hage Chahine JM
    Biochemistry; 2010 Dec; 49(48):10261-3. PubMed ID: 21049900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium.
    Skarżyńska E; Żytyńska-Daniluk J; Lisowska-Myjak B
    J Trace Elem Med Biol; 2017 Sep; 43():58-62. PubMed ID: 27903408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactoferrin from human breast milk and from neutrophil granulocytes. Comparative studies of isolation, quantitation, characterization and iron binding properties.
    Bezwoda WR; Mansoor N
    Biomed Chromatogr; 1989 May; 3(3):121-6. PubMed ID: 2765693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of ceruloplasmin by lactoferrin against hydroxyl radicals is pH dependent.
    Sokolov AV; Solovyov KV; Kostevich VA; Chekanov AV; Pulina MO; Zakharova ET; Shavlovski MM; Panasenko OM; Vasilyev VB
    Biochem Cell Biol; 2012 Jun; 90(3):397-404. PubMed ID: 22397552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding properties of lactoferrin and lysozyme.
    Zou S; Magura CE; Hurley WL
    Comp Biochem Physiol B; 1992 Dec; 103(4):889-95. PubMed ID: 1478067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins.
    Samygina VR; Sokolov AV; Bourenkov G; Petoukhov MV; Pulina MO; Zakharova ET; Vasilyev VB; Bartunik H; Svergun DI
    PLoS One; 2013; 8(7):e67145. PubMed ID: 23843990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the molecular heterogeneity of ceruloplasmin from human blood and breast milk.
    Puchkova LV; Zakharova ET; Aleinikova TD; Mokshina SV; Tsymbalenko NV; Sasina LK; Shirmanova MR; Rogacheva NP; Gaitskhoki VS
    Biochemistry (Mosc); 1997 Aug; 62(8):928-30. PubMed ID: 9360306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceruloplasmin Reduces the Lactoferrin/Oleic Acid Antitumor Complex-Mediated Release of Heme-Containing Proteins from Blood Cells.
    Elizarova AY; Sokolov AV; Vasilyev VB
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.